Understanding Your Cancer: Oncomine Focus Panel PDL1 Testing
When you’re facing a cancer diagnosis, having precise information about your specific cancer type can transform your treatment journey. The Oncomine Focus Panel PDL1 test provides the comprehensive genetic insights your oncologist needs to create a personalised treatment plan that targets your cancer’s unique characteristics.
What This Advanced Cancer Test Reveals
The Oncomine Focus Panel PDL1 combines cutting-edge Next Generation Sequencing (NGS) with Immunohistochemistry (IHC) to analyse your tumour tissue at a molecular level. This comprehensive approach identifies specific genetic mutations and biomarkers, including PDL1 expression, that determine how your cancer responds to different treatments.
Think of it as getting a detailed genetic blueprint of your cancer – information that helps your medical team choose therapies that are most likely to be effective while avoiding treatments that may not work for your specific cancer type.
Who Should Consider This Comprehensive Cancer Analysis?
This test is particularly valuable for patients who:
- Have been diagnosed with solid tumours requiring targeted therapy decisions
- Need guidance on immunotherapy treatment options
- Want to understand if their cancer has specific genetic markers for targeted drugs
- Are exploring personalised treatment approaches beyond standard chemotherapy
- Have cancer types where PDL1 expression influences treatment response
If you’re feeling uncertain about which treatment path to take, this test provides the scientific evidence to guide those important decisions with confidence.
Why This Matters for Your Cancer Treatment Journey
Getting the right information at the right time can significantly impact your treatment outcomes and quality of life. The Oncomine Focus Panel PDL1 test offers:
- Personalised Treatment Guidance: Identifies which targeted therapies and immunotherapies are most likely to work for your specific cancer
- Avoid Unnecessary Treatments: Helps prevent spending time and resources on therapies that may not be effective for your cancer type
- Peace of Mind: Provides scientific evidence to support your treatment decisions
- Comprehensive Analysis: Examines multiple genetic markers simultaneously for a complete picture
- Expert Interpretation: Results are presented in a clear format that your oncologist can easily interpret
Understanding Your Test Results
We understand that waiting for test results can be anxiety-provoking. Your comprehensive report will be available within 20-25 days and will include:
- Detailed analysis of genetic mutations relevant to targeted therapies
- PDL1 expression levels indicating potential response to immunotherapy
- Clear interpretation of what each finding means for your treatment options
- Professional presentation suitable for discussion with your oncology team
Your oncologist will review these results with you, explaining how they influence your treatment plan and what options are now available based on your cancer’s specific characteristics.
Investment in Your Personalised Cancer Care
| Test Option | Regular Price | Special Price | Savings |
|---|---|---|---|
| Oncomine Focus Panel PDL1 | ZAR 23,350 | ZAR 17,500 | ZAR 5,850 |
This comprehensive analysis represents significant value compared to the cost of ineffective treatments or delayed responses. Many medical aids recognise the importance of this testing in optimising cancer care.
Why Trust Oracle Genomics With Your Cancer Testing?
At Oracle Genomics, we combine cutting-edge technology with compassionate patient care:
- Nationwide Coverage: Available across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Expert Technology: State-of-the-art NGS and IHC methodologies ensure accurate, reliable results
- Medical Professional Collaboration: We work closely with your oncology team to ensure seamless integration of results
- Patient-Focused Approach: We understand the emotional journey of cancer diagnosis and provide supportive, clear communication
- Quality Assurance: Rigorous quality control processes guarantee the reliability of your results
Take the Next Step in Your Cancer Care Journey
Don’t leave your treatment decisions to chance. The insights from the Oncomine Focus Panel PDL1 test can provide the clarity and confidence you need to move forward with your cancer treatment.
Important Note: This test requires a doctor’s prescription and is performed using paraffin-embedded tumour tissue blocks from your biopsy or surgery.
Every day counts in your cancer journey. Get the precise information you need to make informed treatment decisions with confidence.
